In Vitro: JNJ 10329670 (0-100 μM) inhibits cathepsin S and thereby block the proteolysis of the invariant chain in human B cell lines. JNJ 10329670 (0-10 μM) blocks proliferation of T cells in response to both antigens, but less so to the nonspecific T cell mitogen phytohemagglutinin.